Literature DB >> 310744

Theophylline modulation of E-rosette formation: an indicator of T-cell maturation.

S Limatibul, A Shore, H M Dosch, E W Gelfand.   

Abstract

The binding of unsensitized sheep erythrocytes is a characteristic of human thymus dependent T-lymphocytes. We have investigated the effect of theophylline on E-rosette formation using cells from normal individuals, and patients with immunodeficiency or acute lymphoblastic leukaemia, and have attempted to correlate the influence of the drug on distinct T-lymphocyte subpopulations. Three subpopulations of E-rosetting T-lymphocytes can be delineated: theophylline-sensitive T-cells which lose the capacity to form E-rosettes following treatment; theophylline-resistant T-cells which are unaffected by the drug; and theophylline-dependent cells which acquire the ability to form E-rosettes following incubation with theophylline. The action of theophylline was shown to be dose-dependent, temperature-dependent and reversible. Reversibility or re-expression of the receptor for sheep red cells could be blocked by the addition of puromycin. In peripheral blood, E-rosetting T-lymphocytes were roughly divided into two equal populations, one sensitive, the other resistant. Thymocytes were shown to be entirely theophylline-resistant, whereas a small population of cells in peripheral blood and bone marrow were induced to become E-rosetting in the presence of theophylline. Induction by theophylline may be effective at a distinct stage of precursor T-cell differentiation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 310744      PMCID: PMC1537427     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

Review 1.  Thymic factors.

Authors:  J F Bach; C Carnaud
Journal:  Prog Allergy       Date:  1976

2.  Beta-adrenergic inhibition of human T lymphocyte rosettes.

Authors:  S P Galant; R A Remo
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

3.  Modulation of human T lymphocyte rosette formation by autonomic agonists and cyclic nucleotides.

Authors:  M H Grieco; I Siegel; Z Goel
Journal:  J Allergy Clin Immunol       Date:  1976-07       Impact factor: 10.793

4.  Studies on the effect of various agents on the maturation of thymus stem cells.

Authors:  U Singh; J J Owen
Journal:  Eur J Immunol       Date:  1975-04       Impact factor: 5.532

5.  Induction and separation of antigen-dependent T helper and T suppressor cells in man.

Authors:  A Shore; H Dosch; E W Gelfand
Journal:  Nature       Date:  1978-08-10       Impact factor: 49.962

6.  Partial purine nucleoside phosphorylase deficiency. Studies of lymphocyte function.

Authors:  E W Gelfand; H M Dosch; W D Biggar; I H Fox
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

7.  Rosette formation between human lymphocytes and sheep erythrocytes. Inhibition of rosette formation by specific glycopeptides.

Authors:  D H Boldt; J P Armstrong
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

8.  Surface markers and prognostic factors in acute lymphoblastic leukemia.

Authors:  I Tsukimoto; K Y Wong; B C Lampkin
Journal:  N Engl J Med       Date:  1976-01-29       Impact factor: 91.245

9.  Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity.

Authors:  E R Giblett; A J Ammann; D W Wara; R Sandman; L K Diamond
Journal:  Lancet       Date:  1975-05-03       Impact factor: 79.321

10.  Differences in effect of isoproterenol stimulation on levels of cyclic AMP in human B and T lymphocytes.

Authors:  P Niaudet; G Beaurain; M A Bach
Journal:  Eur J Immunol       Date:  1976-11       Impact factor: 5.532

View more
  20 in total

1.  Lymphocyte chemotaxis in inflammation. X. Heterogeneity of chemotactic responsiveness in human T subsets towards lymphocyte chemotactic factors from delayed hypersensitivity reaction site.

Authors:  Y Mibu; Y Shimokaway; H Hayashi
Journal:  Immunology       Date:  1985-07       Impact factor: 7.397

Review 2.  Adenosine and adenosine receptors in immune function. Minireview and meeting report.

Authors:  R B Gilbertsen
Journal:  Agents Actions       Date:  1987-10

3.  Familial progressive systemic sclerosis (scleroderma): immunological analysis of two patients and six siblings from a single kindred.

Authors:  E Soppi; A Lehtonen; A Toivanen
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

Review 4.  The use of concanavalin A to study the immunoregulation of human T cells.

Authors:  J M Dwyer; C Johnson
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

5.  Selective defect of a T helper subpopulation in severe combined immunodeficiency.

Authors:  L Businco; F Pandolfi; P Rossi; D Del Principe; M Fiorilli; I Quinti; F Aiuti
Journal:  J Clin Immunol       Date:  1981-04       Impact factor: 8.317

6.  In vivo effects of a single infusion of theophylline on human peripheral blood lymphocytes.

Authors:  R Pardi; M R Zocchi; E Ferrero; G F Ciboddo; L Inverardi; C Rugarli
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

7.  Abnormal adenosine-induced immunosuppression and cAMP metabolism in T lymphocytes of patients with systemic lupus erythematosus.

Authors:  R Mandler; R E Birch; S H Polmar; G M Kammer; S A Rudolph
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

8.  Human post-thymic precursor cells in health and disease. I. Characterization of the autologous rosette-forming T cells as post-thymic precursors.

Authors:  R Palacios; D Alarcón-Segovia; L Llorente; A Ruíz-Arguelles; E Díaz-Jouanen
Journal:  Immunology       Date:  1981-01       Impact factor: 7.397

9.  Immune complex-dependent T cell-mediated cytostasis (IDTC).

Authors:  J Tanaka; J Yata
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

10.  Carbamycholine modulation of E-rosette formation: identification of nicotinic acetylcholine receptors on a subpopulation of human T lymphocytes.

Authors:  Y Mizuno; H M Dosch; E W Gelfand
Journal:  J Clin Immunol       Date:  1982-10       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.